Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract. Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule.

[1]  Y. Yiangou,et al.  Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacology. , 1984, Endocrinology.

[2]  J. Polak,et al.  Studies on the distribution of PHI in mammals , 1984, Peptides.

[3]  Y. Yiangou,et al.  The distributions of PHI and VIP in porcine gut and their co-localisation to a proportion of intrinsic ganglion cells , 1984, Peptides.

[4]  Toshimitsu Suzuki,et al.  Production of VIP- and PHM (human PHI)-related peptides in human neuroblastoma cells , 1984, Peptides.

[5]  J. Polak,et al.  DIARRHOEA IN VIPOMA PATIENTS ASSOCIATED WITH COSECRETION OF A SECOND ACTIVE PEPTIDE (PEPTIDE HISTIDINE ISOLEUCINE) EXPLAINED BY SINGLE CODING GENE , 1983, The Lancet.

[6]  H. Okamoto,et al.  Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27 , 1983, Nature.

[7]  P. Lins,et al.  Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats. , 1983, Endocrinology.

[8]  V. Mutt,et al.  Isolation of a brain peptide identical to the intestinal PHI (peptide HI) , 1983, FEBS letters.

[9]  Y. Yiangou,et al.  ARE PEPTIDE HISTIDINE ISOLEUCINE AND VASOACTIVE INTESTINAL PEPTIDE CO-SYNTHESISED IN THE SAME PRO-HORMONE? , 1982, The Lancet.

[10]  T. Hökfelt,et al.  PHI, a VIP-like peptide, is present in the rat median eminence. , 1982, Acta physiologica Scandinavica.

[11]  Y. Yiangou,et al.  PHI stimulates intestinal fluid secretion , 1982, Neuropeptides.

[12]  Y. Yiangou,et al.  Distribution of PHI in the mammalian respiratory tract and some aspects of its pharmacology , 1982, Regulatory Peptides.

[13]  J. Lundberg,et al.  Vascular effects of the peptides PYY and PHI: comparison with APP and VIP. , 1982, European journal of pharmacology.

[14]  V. Mutt,et al.  Actions of a newly isolated intestinal peptide PHI on pancreatic acini. , 1981, The American journal of physiology.

[15]  V. Mutt,et al.  Isolation and characterization of the intestinal peptide porcine PHI (PHI-27), a new member of the glucagon--secretin family. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Dockray,et al.  Actions of a new peptide from porcine intestine (PHI) on pancreatic secretion in the rat and turkey. , 1980, Life sciences.

[17]  V. Mutt,et al.  Porcine peptide having N‐terminal histidine and C‐terminal isoleucine amide (PHI) , 1980, FEBS letters.

[18]  V. Mutt,et al.  Interaction of a newly isolated intestinal polypeptide (PHI) with glucose and arginine to effect the secretion of insulin and glucagon. , 1980, Life sciences.

[19]  S. Bloom,et al.  Measurement of fasting and postprandial plasma VIP in man. , 1978, Gut.

[20]  J. Tait,et al.  Properties of rat adrenal zona reticularis cells: preparation by gravitational sedimentation. , 1978, The Journal of endocrinology.

[21]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.

[22]  A. H. Coons,et al.  STUDIES ON ANTIBODY PRODUCTION VIII. THE INHIBITORY EFFECT OF CHLORAMPHENICOL ON THE SYNTHESIS OF ANTIBODY IN TISSUE CULTURE , 1963 .

[23]  A. H. Coons,et al.  STUDIES ON ANTIBODY PRODUCTION I. A METHOD FOR THE HISTOCHEMICAL DEMONSTRATION OF SPECIFIC ANTIBODY AND ITS APPLICATION TO A STUDY OF THE HYPERIMMUNE RABBIT , 1955 .

[24]  Y. Yiangou,et al.  Distribution of PHI in the rat brain , 1982 .

[25]  T. Laurent,et al.  A theory of gel filtration and its exeperimental verification , 1964 .